Hiroyuki Miyoshi

Dr. Hiroyuki Miyoshi

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2019 in Molecular Brain
Verified
Journal Article
Open access
PDF file
RTRyota Tamura
Ryota Tamura
HMHiroyuki Miyoshi
Hiroyuki Miyoshi
OSOltea Sampetrean
Oltea Sampetrean
MSMunehisa Shinozaki
Munehisa Shinozaki
YMYukina Morimoto
Yukina Morimoto
MTMasahiro Toda
Masahiro Toda
Glioblastoma exhibits phenotypic and genetic heterogeneity, aggressive invasiveness, therapeutic resistance, and tumor recurrence, which can be explained by the existence of glioma stem cells (GSCs). In this study, we visualized the spatiotemporal dynamics of invasion of human GSCs in an orthotopic xenograft mouse model using time-lapse imaging of organotypic brain slice cultures and three-dimensional imaging of optically cleared whole brains. GSCs implanted in the striatum exhibited directional migration toward axon bundles, perivascular area, and the subventricular zone around the inferior horn of the lateral ventricle. GSCs migrated in a helical pattern around axon bundles in the striatum and invaded broadly in both the rostral and caudal directions. GSCs in the corpus callosum migrated more rapidly and unidirectionally toward the contralateral side with pseudopod extension. These characteristics of GSC invasion shared histological features observed in glioblastoma patients. Spatiotemporal visualization techniques can contribute to the elucidation of the mechanisms underlying GSC invasion that may lead to the development of effective therapy for glioblastoma.

Verified
Journal Article
Open access
PDF file
CIChizuru Iwasawa
Chizuru Iwasawa
RTRyota Tamura
Ryota Tamura
Yuki SugiuraYuki Sugiura
Yuki Sugiura
SSSadafumi Suzuki
Sadafumi Suzuki
NKNaoko Kuzumaki
Naoko Kuzumaki
HMHiroyuki Miyoshi
Hiroyuki Miyoshi
Human induced pluripotent stem cells (iPSCs) hold enormous promise for regenerative medicine. The major safety concern is the tumorigenicity of transplanted cells derived from iPSCs. A potential solution would be to introduce a suicide gene into iPSCs as a safety switch. The herpes simplex virus type 1 thymidine kinase (HSV-TK) gene, in combination with ganciclovir, is the most widely used enzyme/prodrug suicide system from basic research to clinical applications. In the present study, we attempted to establish human iPSCs that stably expressed HSV-TK with either lentiviral vectors or CRISPR/Cas9-mediated genome editing. However, this task was difficult to achieve, because high-level and/or constitutive expression of HSV-TK resulted in the induction of cell death or silencing of HSV-TK expression. A nucleotide metabolism analysis suggested that excessive accumulation of thymidine triphosphate, caused by HSV-TK expression, resulted in an imbalance in the dNTP pools. This unbalanced state led to DNA synthesis inhibition and cell death in a process similar to a “thymidine block”, but more severe. We also demonstrated that the Tet-inducible system was a feasible solution for overcoming the cytotoxicity of HSV-TK expression. Our results provided a warning against using the HSV-TK gene in human iPSCs, particularly in clinical applications.

1 August 2013 in Biology of Reproduction
Verified
Journal Article
Open access
SKSatoshi Kamimura
Satoshi Kamimura
KIKimiko Inoue
Kimiko Inoue
NONarumi Ogonuki
Narumi Ogonuki
MHMichiko Hirose
Michiko Hirose
MOMami Oikawa
Mami Oikawa
AOAtsuo Ogura
Atsuo Ogura
Somatic cell nuclear transfer (SCNT) is a unique technology that produces cloned animals from single cells. It is desirable from a practical viewpoin

Verified
Journal Article
Open access
PDF file
TUTomohiko C. Umei
Tomohiko C. Umei
HYHiroyuki YAMAKAWA
Hiroyuki YAMAKAWA
NMNaoto Muraoka
Naoto Muraoka
TSTaketaro Sadahiro
Taketaro Sadahiro
MIMari Isomi
Mari Isomi
MIMasaki Ieda
Masaki Ieda
Direct reprogramming is a promising approach in regenerative medicine. Overexpression of the cardiac transcription factors Gata4, Mef2c, and Tbx5 (GMT) or GMT plus Hand2 (GHMT) directly reprogram fibroblasts into cardiomyocyte-like cells (iCMs). However, the critical timing of transgene expression and the molecular mechanisms for cardiac reprogramming remain unclear. The conventional doxycycline (Dox)-inducible temporal transgene expression systems require simultaneous transduction of two vectors (pLVX-rtTA/pLVX-cDNA) harboring the reverse tetracycline transactivator (rtTA) and the tetracycline response element (TRE)-controlled transgene, respectively, leading to inefficient cardiac reprogramming. Herein, we developed a single-construct-based polycistronic Dox-inducible vector (pDox-cDNA) expressing both the rtTA and TRE-controlled transgenes. Fluorescence activated cell sorting (FACS) analyses, quantitative RT-PCR, and immunostaining revealed that pDox-GMT increased cardiac reprogramming three-fold compared to the conventional pLVX-rtTA/pLVX-GMT. After four weeks, pDox-GMT-induced iCMs expressed multiple cardiac genes, produced sarcomeric structures, and beat spontaneously. Co-transduction of pDox-Hand2 with retroviral pMX-GMT increased cardiac reprogramming three-fold compared to pMX-GMT alone. Temporal Dox administration revealed that Hand2 transgene expression is critical during the first two weeks of cardiac reprogramming. Microarray analyses demonstrated that Hand2 represses cell cycle-promoting genes and enhances cardiac reprogramming. Thus, we have developed an efficient temporal transgene expression system, which could be invaluable in the study of cardiac reprogramming.

1 January 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MYMasahiro Yo
Masahiro Yo
ASAsako Sakaue-Sawano
Asako Sakaue-Sawano
SNShinichi Noda
Shinichi Noda
AMAtsushi Miyawaki
Atsushi Miyawaki
HMHiroyuki Miyoshi
Hiroyuki Miyoshi

1 August 2012 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TYTomoyuki Yamaguchi
Tomoyuki Yamaguchi
AMAzusa Morikawa
Azusa Morikawa
HMHiroyuki Miyoshi
Hiroyuki Miyoshi